Leuprolide Acetate Market Professional Survey Report 2019

Leuprolide Acetat is a synthetic nonapeptide that is a potent gonadotropin-releasing hormone receptor (GnRHR) agonist used for diverse clinical applications, including the treatment of prostate cancer, endometriosis, uterine fibroids, central precocious puberty and in vitro fertilization techniques. Leuprolide acetate is given by injection into a muscle or under the skin.

Leuprorelin was approved for medical use in the United States in 1985. It is on the World Health Organization’s List of Essential Medicines, the most effective and safe medicines needed in a health system. In the United Kingdom a monthly dose costs the NHS about 75.24 pounds. In the United States the equivalent dose has a wholesale cost of 1,011.93 USD.

Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-leuprolide-acetate-2019-634

The global Leuprolide Acetate market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019–2025.

This report focuses on Leuprolide Acetate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Leuprolide Acetate market size by analyzing historical data and future prospect.

Regionally, this report categorizes the production, apparent consumption, export and import of Leuprolide Acetate in North America, Europe, China, Japan, Southeast Asia and India.

For each manufacturer covered, this report analyzes their Leuprolide Acetate manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:

  • Tolmar Pharmaceuticals
  • Varian Pharmed
  • Avenit
  • Takeda Pharmaceutical
  • Sun Pharmaceutical Industries
  • Livzon Pharmaceutical
  • Beijing Biote Pharmaceutical
  • Soho-YImIng
  • AbbVie
  • Sanofi
  • Astellas Pharma
  • Abbott
  • Merck
  • Pfizer

Segment by Regions

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India

Segment by Type

  • Intramuscular
  • Subcutaneous

Segment by Application

  • Prostate Cancer
  • Precocious
  • Uterine Fibroid
  • Others

Get the Complete Report & TOC @ https://www.grandresearchstore.com/life-sciences/global-leuprolide-acetate-2019-634

Table of content

Executive Summary
1 Industry Overview of Leuprolide Acetate
1.1 Definition of Leuprolide Acetate
1.2 Leuprolide Acetate Segment by Type
1.2.1 Global Leuprolide Acetate Production Growth Rate Comparison by Types (2014–2025)
1.2.2 Intramuscular
1.2.3 Subcutaneous
1.3 Leuprolide Acetate Segment by Applications
1.3.1 Global Leuprolide Acetate Consumption Comparison by Applications (2014–2025)
1.3.2 Prostate Cancer
1.3.3 Precocious
1.3.4 Uterine Fibroid
1.3.5 Others
1.4 Global Leuprolide Acetate Overall Market
1.4.1 Global Leuprolide Acetate Revenue (2014–2025)
1.4.2 Global Leuprolide Acetate Production (2014–2025)
1.4.3 North America Leuprolide Acetate Status and Prospect (2014–2025)
1.4.4 Europe Leuprolide Acetate Status and Prospect (2014–2025)
1.4.5 China Leuprolide Acetate Status and Prospect (2014–2025)
1.4.6 Japan Leuprolide Acetate Status and Prospect (2014–2025)
1.4.7 Southeast Asia Leuprolide Acetate Status and Prospect (2014–2025)
1.4.8 India Leuprolide Acetate Status and Prospect (2014–2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Leuprolide Acetate
2.3 Manufacturing Process Analysis of Leuprolide Acetate
2.4 Industry Chain Structure of Leuprolide Acetate

CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414
Email: help@grandresearchstore.com

Follow Us On linkedin :- https://www.linkedin.com/company/grand-research-store/